Building Value Into 7TM Receptor Genes
 

At 7TM Pharma we focus on developing our pipeline of clinical assets forward with a primary therapeutic focus in obesity, related metabolic diseases and gastrointestinal diseases. These are areas with obvious unmet medicinal needs. According to the WHO, there are more than 400 million clinically obese people worldwide, and the number is growing rapidly.

Our organization supports the preclinical and clinical activities within our internal as well as external collaborative programs, and actively seek collaborative opportunities for our programs.